Sonnet Biotherapeutics Holdings Inc (NASDAQ:SONN)

Delayed Data
As of Nov 30
 +0.03 / +3.03%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Sonnet Biotherapeutics Holdings Inc have a median target of 22.00, with a high estimate of 22.00 and a low estimate of 22.00. The median estimate represents a +2,056.86% increase from the last price of 1.02.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Sonnet Biotherapeutics Holdings Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 17.03%
Growthannually 53.22%


Growthquarterly 61.11%
Growthannually -18.37%
Key to the earnings and sales forecast charts.